Special deliveries: Are designer babies arriving? [With video]
By Mike Celizic,
The TODAY Show
| 03. 03. 2009
[Quotes CGS's Marcy Darnovsky]
Imagine ordering a baby like dinner: “We’ll take the boy in the Greek-god model, but can you make him 6-foot-4 instead of 6 feet? And gimme the green eyes instead of the blue; ash-blond hair — a little curly, but not too much; olive complexion; 140 IQ; heavy on the fast-twitch muscles.”
Sound like science fiction? Maybe not: The news that a California fertility clinic is offering prospective parents the opportunity to improve the odds of having children with preselected hair, skin and eye color has renewed the debate over “designer babies.” (Story continues below video.)
.msnbcLinks {font-size:11px; font-family:Arial, Helvetica, sans-serif; color: #999; margin-top: 5px; background: transparent; text-align: center; width: 425px;} .msnbcLinks a {text-decoration:none !important; border-bottom: 1px dotted #999 !important; font-weight:normal !important; height: 13px;} .msnbcLinks a:link, .msnbcLinks a:visited {color: #5799db !important;} .msnbcLinks a:hover, .msnbcLinks a:active {color:#CC0000 !important;}
Visit msnbc.com for Breaking News, World News, and News about the Economy
But Dr. Jamie Grifo, director of the Division of Reproductive Endocrinology at the NYU School of Medicine, told TODAY’s Meredith Vieira Tuesday in New York that the...
Related Articles
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Jason Kehe, Wired | 04.11.2024
God help the babies! Or, absent God, a fertility startup called Orchid. It offers prospective parents a fantastical choice: Have a regular baby or have an Orchid baby. A regular baby might grow up and get cancer. Or be born...
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...